Serving as a protective barrier in managing wounds
In a randomized controlled trial, Affinity was proven to support wound management when used as a protective barrier
When Affinity was used as a protective barrier as part of the course of wound management, the incidence and time to wound closure vs standard of care in 76 refractory diabetic foot ulcers (DFUs) were significantly improved.
See the RCT resultsCase studies show how Affinity used as a protective barrier supported wound management in a variety of wounds
In various retrospective case studies, results of wound management are shown for DFUs, surgical wounds, venous and arterial wounds, VLUs, and others.
View the case studiesFind comprehensive support with Affinity
View our provider support or talk to an Organogenesis Tissue Regeneration Specialist about supporting your practice with the only fresh, amniotic membrane tissue product on the market.
Contact usPlease refer to the Affinity instructions for use for usage and safety information.
References: Data on File, Organogenesis Inc. Supporting information available upon request.